Surfix BV of Wageningen at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Surfix BV

P.O. Box 286, 6700 AG Wageningen
Bronland 12 B-1, 6708WH Wageningen
Netherlands

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 1): stand D33

Fairground map

MEDICA 2021 fairground map: Hall 1

Contact

Hans Dijk

Business Development Manager

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing
  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.03  Diagnostic tests for cancer
  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.04  Other molecular diagnostics testing

Our products

Product category: Immuno assay testing, Diagnostic tests for cancer, Other molecular diagnostics testing

The future of diagnostics: Surfix's photonic diagnostics platform

The Covid-19 pandemic has made it clear that there is a need for fast and reliable diagnostic tests available in point-of-care (PoC) environments. Many diagnostic tests are still complex and must be performed by trained staff on sizeable equipment in specialized facilities.

Surfix develops a plug-and-play photonic diagnostics platform, delivering a sensitive, fast, and potentially label-free technology that enables detection of multiple biomarkers simultaneously. Features that, along with a low unit cost and the ability to easily scale up production, will revolutionize the world of medical diagnostics by enabling PoC diagnosis and treatment monitoring for a wide variety of conditions.

More Less

About us

Company portrait

The Surfix team has its roots in the surface modification technologies based on organic chemistry. Over the years, we have continually added to this core expertise with complementary technologies such as biosensing and microfluidics. As such our team is versatile, solution-oriented and we like to build and maintain close and cooperative relationships with our partners and customers.